• 36 Citations
  • 4 h-Index
20162019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesca Palombi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Lymphoma Medicine & Life Sciences
Biosimilar Pharmaceuticals Medicine & Life Sciences
Hematopoietic Stem Cell Mobilization Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Autografts Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 36 Citations
  • 4 h-Index
  • 13 Article
  • 1 Letter
1 Citation (Scopus)

The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)

Annibali, O., Hohaus, S., Marchesi, F., Cantonetti, M., Di Rocco, A., Tomarchio, V., Di Napoli, A., Pelliccia, S., Battistini, R., Anticoli Borza, P., Abruzzese, E., Cenfra, N., Andriani, A., Tesei, C., Alma, E., Palombi, F., Pupo, L., Petrucci, L., Becilli, M., Maiolo, E. & 4 others, Bellesi, S., Cuccaro, A., D’Alò, F. & Cox, M. C., Dec 6 2019, In : Leukemia and Lymphoma. 60, 14, p. 3386-3394 9 p.

Research output: Contribution to journalArticle

BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant

Marchesi, F., Capria, S., Giannarelli, D., Trisolini, S. M., Ansuinelli, M., Caputo, M. D., Serrao, A., Gumenyuk, S., Renzi, D., Pupo, L., Palombi, F., Provenzano, I., Di Rocco, A., Pisani, F., Romano, A., Spadea, A., Papa, E., Canfora, M., Cantonetti, M. & Mengarelli, A., Feb 13 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-4 4 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, A. J. M., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, A. M., Merli, M. & 11 others, Gini, G., Cabras, M. G., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

Lymphoma
Confidence Intervals
Febrile Neutropenia
Splenectomy
Infection